Navigation Links
UV Flu Technologies to Commence a National TV Advertising Campaign
Date:5/16/2012

, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's  ("SEC") EDGAR database. For more information, visit: www.uvflutech.com.

About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.)  The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.

In addition, the Company's RxAir subsidiary in Dallas, TX, makes one of the worlds' finest lines of hospital-grade HEPA filtration products. The RX-3000, the Company's main product, is currently in almost 450 hospitals internationally, is FDA cleared as a Class II Medical Device, and has been shown to capture 99.99% of all airborne contaminants. The Company's product lines are in Hospitals, government buildings, casinos and restaurants around the world.

For more information, visit: www.uvflutech.com. Or www.rxair.com

Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange A
'/>"/>

SOURCE UV Flu Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
2. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
3. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
4. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
5. Webb Telescope spinoff technologies already seen in some industries
6. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
7. ODT Forum Presents Regenerative Technologies
8. Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies
9. Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
10. Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration
11. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord ... ) focused on bringing the life saving potential ... that it has reduced its secured debt by a total ... "On April 6th, 2009, Cord Blood America announced it ...
... Precision Engineering), an emerging leader in the ... from fermentation technology, announced that Alex Chu ... of process development. Alex is the ... development for Bristol-Myers Squibb and will lead ...
... available in German . , The ... is able to rapidly ,and efficiently detoxify chemical warfare ... Tokyo subway attacks in 1995. A detailed understanding ,of ... ,necessary for efforts aiming to improve their properties. A ...
Cached Biology Technology:Cord Blood America Says Debt Reduced $4.194 Million in 2009 2Microbia, Inc. Names Alex Chu as Vice President of Process Development 2Structure of enzyme against chemical warfare agents determined 2
(Date:4/14/2014)... greenhouse gas methane were found above shale gas wells ... important emissions source, according to a study jointly led ... implications for the evaluation of the environmental impacts from ... of only a few to use a so-called "top ... air above wells, identified seven individual well pads with ...
(Date:4/14/2014)... A plant growth chamber bound for the International ... SpaceX-3 resupply mission may help expand in-orbit food ... offer astronauts something they don,t take for granted, ... used to study the in-orbit function and performance ... Veggie and its plant "pillows." The investigation will ...
(Date:4/14/2014)... and international collaborators have reconstructed the phylogeny and biological ... tropics, the region of the Earth surrounding the equator. ... uncovered three species new to science, each having previously ... modern studies on this group began, Sturnira ... newest additions were described in a new study, published ...
Breaking Biology News(10 mins):'Problem wells' source of greenhouse gas at unexpected stage of natural gas production 2Veggie will expand fresh food production on space station 2Three new species of yellow-shouldered bats discovered in museum collections 2Three new species of yellow-shouldered bats discovered in museum collections 3
... Mo. Approximately 250,000 people in the United States have ... the most common type of the disease, predominantly affecting males. ... their teens and typically die before the age of 30. ... as a possible way to correct the muscle deterioration, but ...
... high blood pressure related to a salty diet? And could ... diseases such as heart failure? A new University of Michigan ... published in the October issue of the Journal of ... of grapes in reducing cardiovascular risk. The effect is thought ...
... Ore. A new study by researchers in Oregon and ... steelhead during their migration to the sea through two large ... remarkably similar despite one major difference. The Columbia River ... However, the researchers point out, there clearly are other differences ...
Cached Biology News:Scientist clears hurdles for muscular dystrophy therapy 2Scientist clears hurdles for muscular dystrophy therapy 3Grapes may aid a bunch of heart risk factors, animal study finds 2Grapes may aid a bunch of heart risk factors, animal study finds 3Grapes may aid a bunch of heart risk factors, animal study finds 4Salmon smolt survival similar in Columbia and Fraser rivers 2Salmon smolt survival similar in Columbia and Fraser rivers 3Salmon smolt survival similar in Columbia and Fraser rivers 4
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... Immunogen: Peptide ... encompassing the human, mouse, and ... Accession Number: NM_000314 ... Routinely evaluated by immunoblot. ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
Biology Products: